These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9158770)

  • 1. The role of the nonconserved residues at position 167 of class A beta-lactamases in susceptibility to mechanism-based inhibitors.
    Guo F; Dmitrienko GI; Clarke AJ; Viswanatha T
    Microb Drug Resist; 1996; 2(2):261-8. PubMed ID: 9158770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the non-conserved residue at position 104 of class A beta-lactamases in susceptibility to mechanism-based inhibitors.
    Guo F; Huynh J; Dmitrienko GI; Viswanatha T; Clarke AJ
    Biochim Biophys Acta; 1999 Apr; 1431(1):132-47. PubMed ID: 10209286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
    Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes induced by cloxacillin in class a beta-lactamase from Bacillus cereus.
    Salas-Burgos A; Martínez-Oyanedel J; Bunster M
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):985-90. PubMed ID: 14656057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes.
    Lenfant F; Petit A; Labia R; Maveyraud L; Samama JP; Masson JM
    Eur J Biochem; 1993 Nov; 217(3):939-46. PubMed ID: 8223651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis.
    Delaire M; Labia R; Samama JP; Masson JM
    J Biol Chem; 1992 Oct; 267(29):20600-6. PubMed ID: 1400382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
    Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
    Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificities in class A beta-lactamases: preference for penams vs. cephems. The role of residue 237.
    Healey WJ; Labgold MR; Richards JH
    Proteins; 1989; 6(3):275-83. PubMed ID: 2622907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Bacillus cereus 569/H beta-lactamase I by 6-beta-(trifluoromethane sulfonyl)amidopenicillanic acid sulfone and its N-methyl derivative.
    Clarke AJ; Mezes PS; Vice SF; Dmitrienko GI; Viswanatha T
    Biochim Biophys Acta; 1983 Nov; 748(3):389-97. PubMed ID: 6315063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors.
    Mallo S; Pérez-Llarena FJ; Kerff F; Soares NC; Galleni M; Bou G
    J Antimicrob Chemother; 2010 Jun; 65(6):1187-94. PubMed ID: 20382725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary roles of mutations at positions 69 and 242 in a class A beta-lactamase.
    Bonomo RA; Dawes CG; Knox JR; Shlaes DM
    Biochim Biophys Acta; 1995 Feb; 1247(1):113-20. PubMed ID: 7873579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
    Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
    Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of the hydrolytic water molecule in a class A beta-lactamase mutant: crystal structure and kinetics.
    Zawadzke LE; Chen CC; Banerjee S; Li Z; Wäsch S; Kapadia G; Moult J; Herzberg O
    Biochemistry; 1996 Dec; 35(51):16475-82. PubMed ID: 8987980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala.
    Banerjee S; Shigematsu N; Pannell LK; Ruvinov S; Orban J; Schwarz F; Herzberg O
    Biochemistry; 1997 Sep; 36(36):10857-66. PubMed ID: 9283075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.